Cell detachment modulates TRAIL resistance in ovarian cancer cells by downregulating the phosphatidylinositol 3-kinase/Akt pathway

International Journal of Gynecological Cancer

Volumn 18, Issue 4, 2008, Pages 670-676

  Lane, D ^a   Cartier, A ^a   Rancourt, C ^a   Piche A ^a,b  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Apoptosis; Cell adhesion; Ovarian cancer; PI3K Akt pathway; TRAIL

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CASPASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANOIKIS; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL KILLING; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTINEOPLASTIC AGENTS; CARCINOMA; CELL ADHESION; CELL COMMUNICATION; CELL DEATH; CELL SURVIVAL; CHROMONES; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MORPHOLINES; NEOPLASM CIRCULATING CELLS; ONCOGENE PROTEIN V-AKT; OVARIAN NEOPLASMS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED;

EID: 47649100144     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.01062.x     Document Type: Article

References (25)

1. Walczak H, Miller RE, Ariail K et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-induced ligand in vivo. Nat Med 1999 5 : 157 63.
2. Bodmer JL, Holler N, Reynard S et al. TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat Cell Biol 2000 2 : 241 3.
3. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 1996 271 : 12687 90.
4. Kischkel FC, Hellbardt S, Berhmann I et al. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 1995 14 : 5579 88.
5. Partridge EE, Barnes MN. Epithelial ovarian cancer: prevention, diagnosis, and treatment. CA Cancer J Clin 1999 49 : 297 320.
6. Meredith JE, Schwartz ME. Integrins, adhesion, and apoptosis. Trends Cell Biol 1997 7 : 146 50.
7. L. Cancer Res 2001 61 : 4837 41.
8. L is functionally non-equivalent for the regulation of growth and survival in human ovarian cancer cells. Gynecol Oncol 2006 100 : 254 63.
9. Shayestch L, Lu Y, Kuo WL et al. PIK3CA is implicated as an oncogene in ovarian. Nat Genet 1999 21 : 99 102.
10. Campbell IG, Russell SE, Choong DY et al. Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Res 2004 64 : 7678 81.
11. Hu I, Hofmann J, Lu Y, Mills GB, Jaffe RB. Inhibition of phosphatidylinositol 3′-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models. Cancer Res 2002 62 : 1087 92.
12. Lane D, Cartier A, L'Espérance S, Côté SM, Rancourt C, Piché A. Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells. Gynecol Oncol 2004 93 : 594 604.
13. Vignati S, Codegoni A, Polato F, Broggini M. Trail activity in human ovarian cancer cells: potentiation of the action of cytotoxic drugs. Eur J Cancer 2002 38 : 177 83.
14. Cuello M, Ettenberg SA, Nau MM, Lipkowitz S. Synergistic induction of apoptosis by the combination of TRAIL and chemotherapy in chemoresistant ovarian cancer cells. Gynecol Oncol 2001 81 : 380 90.
15. Yu C, Wolf JK, Scanlon D, Price JE, Hung M-C. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A. Cancer Res 1993 53 : 891 8.
16. Khwaja A, Rodriguez-Viciana P, Wennstroöm S, Warne PH, Downward J. Matrix adhesion and Ras transformation both activate a phosphatidylinositol 3-kinase and protein B/Akt cellular pathway. EMBO J 1997 16 : 2783 93.
17. Lee JW, Juliano RL. Alpha5beta1 integrin protects intestinal epithelial cells from apoptosis through a phosphatidylinositol 3-kinase and protein kinase B-dependent pathway. Mol Biol Cell 2000 11 : 1973 87.
18. Kim K, Fisher MJ, Xu S-Q, El-Deiry WS. Molecular determinants of response to TRAIL in killing of normal and cancer cells. Clin Cancer Res 2000 6 : 335 46.
19. Aoudjit F, Vuori K. Matrix attachment regulates Fas-induced apoptosis in endothelial cells: a role for c-flip and implications for anoikis. J Cell Biol 2001 152 : 633 43.
20. Rosen K, Shi W, Calabretta B, Filmus J. Cell detachment triggers p38 mitogen-activated protein kinase-dependent overexpression of Fas ligand. A novel mechanism of anoikis of intestinal epithelial cells. J Biol Chem 2002 277 : 46123 30.
21. Larribere L, Khaled M, Tartare-Deckert S et al. PI3K mediates protection against TRAIL-induced apoptosis in primary human melanocytes. Cell Death Differ 2004 11 : 1084 91.
22. Nesterov A, Lu X, Johnson M, Miller GJ, Ivashchenko Y, Kraft AS. Elevated Akt activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis. J Biol Chem 2001 276 : 10767 74.
23. Kandasamy K, Srivastava RK. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in tumor necrosis-factor-related apoptosis-inducing ligand-induced apoptosis in non-small cell lung cancer cells. Cancer Res 2002 62 : 4929 37.
24. Teraishi F, Kagawa S, Watanabe T et al. ZD1839 (Gefitinib, Iressa), an epidermal growth factor receptor-tyrosine kinase inhibitor, enhances the anti-cancer effects of TRAIL in human esophageal squamous cell carcinoma. FEBS Letters 2005 579 : 4069 75.
25. Shrader M, Pino SM, Lashinger L et al. Gefitinib reverses TRAIL resistance in human bladder cancer cell lines via inhibition of AKT-mediated X-linked inhibitor of apoptosis protein expression. Cancer Res 2007 67 : 1430 5.